Danuglutide vs Tirzepatide

Danuglutide is an experimental GLP-1 drug still in development, while tirzepatide (sold as Mounjaro or Zepbound) is an FDA-approved treatment for type 2 diabetes, obesity, and obstructive sleep apnea. Unlike danuglutide, which targets only the GLP-1 receptor, tirzepatide works on both GLP-1 and GIP receptors. Tirzepatide is available as an injectable medication, while danuglutide’s form and delivery method have not yet been finalized.

AI summary of the sources below.